BUNAZOSIN HCL

Bunazosin hydrochloride shares identical ocular hypotensive effects with good tolerability. Side effects include mild burning, blurred vision, or dizziness.

SKU: 0e9f6d114341 Category: Tag:

Product Description


Mechanism of action

Bunazosin hydrochloride is the water-soluble salt form of bunazosin with identical α₁-antagonist activity. It provides enhanced stability and more predictable solubility for experimental use.

Benefits and advantages

Used in vascular pharmacology, ophthalmic α₁-blockade studies, smooth-muscle tone research, adrenergic-mapping assays and salt-form comparison studies.

Side effects and risks

Risks include orthostatic hypotension, dizziness, nasal congestion and mild cardiac effects. Handle with vascular-active compound precautions.

Datasheet


Molecular Formula

C19H28ClN5O3

Molecular Weight

409.9 g/mol

CAS Number

52712-76-2

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance.

Purity

Purity information is available upon request (COA).

Synonym

bunazosin hydrochloride; 52712-76-2; Detantol; Bunazosin HCl; E-643

IUPAC/Chemical Name

1-[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)-1,4-diazepan-1-yl]butan-1-one;hydrochloride

InChl Key

NBGBEUITCPENLJ-UHFFFAOYSA-N

InChl Code

InChI=1S/C19H27N5O3.ClH/c1-4-6-17(25)23-7-5-8-24(10-9-23)19-21-14-12-16(27-3)15(26-2)11-13(14)18(20)22-19;/h11-12H,4-10H2,1-3H3,(H2,20,21,22);1H

References

https://pubchem.ncbi.nlm.nih.gov/compound/115305;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download